Inotiv (STU:BS50) Cyclically Adjusted Revenue per Share: €10.27 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Inotiv Cyclically Adjusted Revenue per Share?

Inotiv STU:BS50 Cyclically Adjusted Revenue per Share is €10.27 as of Mar. 2026. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Inotiv's adjusted revenue per share for the three months ended in Mar. 2026 was €2.937. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €10.27 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Inotiv's average Cyclically Adjusted Revenue Growth Rate was 13.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 23.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 27.20% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 7.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Inotiv was 34.90% per year. The lowest was -12.40% per year. And the median was -1.70% per year.

As of today (2026-08-08), Inotiv's current stock price is €0.04. Inotiv's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €10.27. Inotiv's Cyclically Adjusted PS Ratio of today is 0.00.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Inotiv was 14.19. The lowest was 0.01. And the median was 0.46.


Inotiv  (STU:BS50) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Inotiv's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.04/10.27
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Inotiv was 14.19. The lowest was 0.01. And the median was 0.46.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Inotiv Cyclically Adjusted Revenue per Share Related Terms


Inotiv Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Inotiv's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inotiv Cyclically Adjusted Revenue per Share Chart

Inotiv Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 7.81 8.77 9.50

Inotiv Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.67 9.39 9.50 9.20 10.27

STU:BS50 vs NSTM, PRPH, IDTA: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Inotiv's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inotiv Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inotiv's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Inotiv's Cyclically Adjusted PS Ratio falls into.



Inotiv Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Inotiv's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=2.937/330.2130*330.2130
=2.937

Current CPI (Mar. 2026) = 330.2130.

Inotiv Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.555 241.018 0.760
201609 0.566 241.428 0.774
201612 0.673 241.432 0.920
201703 0.683 243.801 0.925
201706 0.594 244.955 0.801
201709 0.562 246.819 0.752
201712 0.517 246.524 0.693
201803 0.549 249.554 0.726
201806 0.625 251.989 0.819
201809 0.750 252.439 0.981
201812 0.740 251.233 0.973
201903 0.804 254.202 1.044
201906 0.916 256.143 1.181
201909 1.278 256.759 1.644
201912 1.090 256.974 1.401
202003 1.336 258.115 1.709
202006 1.283 257.797 1.643
202009 1.219 260.280 1.547
202012 1.335 260.474 1.692
202103 1.413 264.877 1.762
202106 1.235 271.696 1.501
202109 1.539 274.310 1.853
202112 3.528 278.802 4.179
202203 5.033 287.504 5.781
202206 6.403 296.311 7.136
202209 5.936 296.808 6.604
202212 4.526 296.797 5.036
202303 5.507 301.836 6.025
202306 5.586 305.109 6.046
202309 5.173 307.789 5.550
202312 4.823 306.746 5.192
202403 4.240 312.332 4.483
202406 3.781 314.175 3.974
202409 4.519 315.301 4.733
202412 4.215 315.605 4.410
202503 3.383 319.799 3.493
202506 3.298 322.561 3.376
202509 3.424 324.800 3.481
202512 3.004 324.054 3.061
202603 2.937 330.213 2.937

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €10.27 mean?
Inotiv (STU:BS50) has a Cyclically Adjusted Revenue per Share of €10.27 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Inotiv and its competitors.
Is Inotiv's Cyclically Adjusted Revenue per Share too high?
Inotiv's current Cyclically Adjusted Revenue per Share is €10.27.
How does Inotiv's Cyclically Adjusted Revenue per Share compare to NSTM and PRPH?
Inotiv's Cyclically Adjusted Revenue per Share of €10.27 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Inotiv and its competitors. Inotiv's current Cyclically Adjusted Revenue per Share is €10.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inotiv stock overvalued right now?
Based on GuruFocus' analysis, Inotiv (STU:BS50) is currently considered Possible Value Trap. The stock's GF Value™ is €1.43, compared to a current price of €0.04 — trading 97.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €10.27. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Inotiv (STU:BS50), the current Cyclically Adjusted Revenue per Share is €10.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inotiv Business Description

Other Exchanges NOTVQ:USA
Address 2701 Kent Avenue, West Lafayette, IN, USA, 47906
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.